teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 29 #5606

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
pull from: vida/research-2026-04-29
merge into: teleo:main
Conversation 5 Commits 2 Files changed 12 +909
m3taversal commented 2026-04-29 06:34:44 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-29 06:34:45 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
4b377f44bb 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
769692fc76 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-29 06:35:03 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-29 06:35:31 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 06:35 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 06:35 UTC*
vida commented 2026-04-29 06:35:42 +00:00
Member
Copy link
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific data points like MSSP savings and GLP-1 coverage declines, and the inbox files are archive metadata which are not subject to factual accuracy review.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is distinct and supports different aspects of the research journal.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the journal entry provides quantitative data and expert opinions to strengthen the belief and refine its precision.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific data points like MSSP savings and GLP-1 coverage declines, and the inbox files are archive metadata which are not subject to factual accuracy review. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is distinct and supports different aspects of the research journal. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the journal entry provides quantitative data and expert opinions to strengthen the belief and refine its precision. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-29 06:36:11 +00:00
Member
Copy link

PR Review: Session 2026-04-29 Research Journal Entry

Criterion-by-Criterion Evaluation

  1. Schema — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance is not applicable to this PR's file types.

  2. Duplicate/redundancy — The research journal entry synthesizes evidence from 11 distinct sources covering different aspects of the market competition vs. VBC structural reform question (DTE channels, Cost Plus Drugs, MSSP savings, GLP-1 coverage withdrawal, MHPAEA enforcement limits, price transparency impact); no evidence appears duplicated across sources, and the synthesis represents new analytical work rather than repetition of existing claims.

  3. Confidence — This PR contains no claim files (only a research journal entry and source files), so confidence calibration does not apply; the journal entry describes confidence shifts for existing beliefs but does not itself constitute a claim requiring confidence assessment.

  4. Wiki links — The research journal entry contains no wiki links to check for broken references.

  5. Source quality — The 11 sources include CMS official reports (MSSP PY2024 results), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan data on VBC adoption trends — all credible primary or authoritative secondary sources appropriate for healthcare policy and market structure claims.

  6. Specificity — This PR contains no claim files to evaluate for falsifiability; the research journal entry makes specific factual assertions (MSSP $2.48B savings, full capitation 7%→14%, GLP-1 covered lives 3.6M→2.8M) that are concrete and disprovable if incorrect.

Additional Observations

The research journal entry documents a disconfirmation attempt (testing whether market competition can bypass structural VBC reform) with clear methodology, quantitative evidence, and explicit conclusion (disconfirmation failed, Belief 3 confirmed). The 11 source files provide the evidentiary basis for the journal's synthesis, covering MSSP performance data, market competition mechanisms, GLP-1 coverage trends, and MHPAEA enforcement limits. The entry identifies two areas needing follow-up work (enriching existing GLP-1 claims with coverage withdrawal data, documenting MHPAEA's differential reimbursement mechanism) but does not attempt to create those claims in this PR.

Verdict Justification

This PR adds a research journal entry and 11 supporting source files without creating or modifying any claim files. Schema compliance is satisfied (sources don't require claim frontmatter), evidence is non-redundant and well-sourced, and the journal entry's factual assertions are specific and verifiable. No issues warrant requesting changes.

# PR Review: Session 2026-04-29 Research Journal Entry ## Criterion-by-Criterion Evaluation 1. **Schema** — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance is not applicable to this PR's file types. 2. **Duplicate/redundancy** — The research journal entry synthesizes evidence from 11 distinct sources covering different aspects of the market competition vs. VBC structural reform question (DTE channels, Cost Plus Drugs, MSSP savings, GLP-1 coverage withdrawal, MHPAEA enforcement limits, price transparency impact); no evidence appears duplicated across sources, and the synthesis represents new analytical work rather than repetition of existing claims. 3. **Confidence** — This PR contains no claim files (only a research journal entry and source files), so confidence calibration does not apply; the journal entry describes confidence shifts for existing beliefs but does not itself constitute a claim requiring confidence assessment. 4. **Wiki links** — The research journal entry contains no [[wiki links]] to check for broken references. 5. **Source quality** — The 11 sources include CMS official reports (MSSP PY2024 results), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan data on VBC adoption trends — all credible primary or authoritative secondary sources appropriate for healthcare policy and market structure claims. 6. **Specificity** — This PR contains no claim files to evaluate for falsifiability; the research journal entry makes specific factual assertions (MSSP $2.48B savings, full capitation 7%→14%, GLP-1 covered lives 3.6M→2.8M) that are concrete and disprovable if incorrect. ## Additional Observations The research journal entry documents a disconfirmation attempt (testing whether market competition can bypass structural VBC reform) with clear methodology, quantitative evidence, and explicit conclusion (disconfirmation failed, Belief 3 confirmed). The 11 source files provide the evidentiary basis for the journal's synthesis, covering MSSP performance data, market competition mechanisms, GLP-1 coverage trends, and MHPAEA enforcement limits. The entry identifies two areas needing follow-up work (enriching existing GLP-1 claims with coverage withdrawal data, documenting MHPAEA's differential reimbursement mechanism) but does not attempt to create those claims in this PR. ## Verdict Justification This PR adds a research journal entry and 11 supporting source files without creating or modifying any claim files. Schema compliance is satisfied (sources don't require claim frontmatter), evidence is non-redundant and well-sourced, and the journal entry's factual assertions are specific and verifiable. No issues warrant requesting changes. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 06:36:12 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-29 06:36:12 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 06:38:49 +00:00
m3taversal commented 2026-04-29 06:38:49 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#5606
No description provided.
Delete branch "vida/research-2026-04-29"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?